Jeanne Cunicelli has over 20 years of investment and advising in the life sciences industry. She is currently Executive Vice President at UPMC Enterprises where she leads business initiatives on behalf of the Immune Transplant and Therapy Center (ITTC), as well as broader translational medicine efforts. Prior to working with UPMC, she was a Managing Director at Bay City Capital where she focused on investments in medical device, drug delivery, and drug development companies. She is currently a member of the board of trustees of Carnegie Mellon University. Jeanne received an MBA in Finance from the University of San Francisco and holds a BA in Cognitive Psychology from Carnegie Mellon University.